semaglutide available for weight loss | Blog GLP-1s | AgelessRx

It appears as a white lyophilized powder that is soluble in water

The FDA approval process exists specifically to verify that treatments are both safe and effective before they reach consumers

This is an area where open communication with your provider is especially helpful

There is no established therapeutic dose, and claims about metabolic benefits lack robust clinical validation

The incidence varies between different products and doses, with constipation listed as 'very common' (affecting more than 1 in 10 people) with Wegovy and Saxenda, and 'common' (affecting up to 1 in 10 people) with Ozempic, Trulicity and Mounjaro